NCT02682485 2023-04-26
SES-DTA
University of Chicago
Phase 2 Withdrawn
Clinical Trials
3 trialsNCT03891979 2020-06-26
Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma
NYU Langone Health
Phase 4 Withdrawn
NCT02252978 2018-07-05
Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy
Wake Forest University Health Sciences
Phase 2 Withdrawn